Everything you need to know about treatment options for Type 1 and Type 2 Diabetes. Learn about the best medicines and the keep up with the latest research.
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2
Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global
A Minnesota based health insurer, Medica, announced today it will expand its cap on the maximum amount members in North Dakota will pay for their
Less than half of the estimated 22 million people prescribed one or more diabetes medications are maintaining blood sugar levels within the
Medically reviewed by Zara Risoldi Cochrane, PharmD, MS, FASCP on April 24, 2019 — Written by Victor Nguyen, PharmD, MS. Republished with
Eli Lilly and Company announced its generic, half-priced version of Humalog insulin is now available for order in pharmacies across the U.S. The
Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the
Medically reviewed by Catherine C. Peng, PharmD, BCPS on 4/17/19. Written by Lindsay Slowiczek, PharmD. Republished with permission from Healthline.
Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to
Medically reviewed by Lindsay Slowiczek, PharmD on April 5, 2019. Written by Victor Nguyen, PharmD, MS. Republished with permission from Healthline.
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: